Abiomed Crushed Its Earnings Estimates, but the Market Wasn't Impressed

On Thursday, Abiomed (NASDAQ: ABMD) announced its results for its third quarter, delivering a major beat on its bottom-line estimates. The market was expecting $1.09 a share in earnings, but got $1.51 a share instead. Profits were up 57% from a year ago.